Basic Information
| LncRNA/CircRNA Name | RAB31 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | renal cancer |
| ICD-0-3 | C64.9 |
| Methods | qPCR |
| Sample | renal cancer cell lines(ACHN and HK-2) |
| Expression Pattern | up-regulated |
| Function Description | Consistent with the results from the microarray analysis, both RAB31 and ACTN4 were upregulated in RCC cells compared with levels in the normal cells. The expression levels of RAB31 (HR=1.017, 95% CI, 0.971-1.432) and ACTN4 (HR=1.130, 95% CI, 1.011-1.659) were negatively correlated with the overall survival of patients (P<0.05). |
| Pubmed ID | 29901101 |
| Year | 2018 |
| Title | Prognostic Signatures for Renal Cancer as Identified by Long Non-Coding and miRNA Competing Endogenous Network Analysis |
External Links
| Links for RAB31 | GenBank HGNC NONCODE |
| Links for renal cancer | OMIM COSMIC |